Aligos Therapeutics (ALGS) Current Leases (2019 - 2026)
Aligos Therapeutics' (ALGS) quarterly Current Leases came in at $3.6 million in Q1 2026, up 9662.16% YoY from $37000.0 in Q1 2025, and up 0.89% on a QoQ basis from $3.6 million in Q4 2025.
Aligos Therapeutics (ALGS) Current Leases (2019 - 2026) Analysis & Trends
Aligos Therapeutics (ALGS) has 8 years of Current Leases data on file, last reported at $3.6 million in Q1 2026.
- Quarterly Current Leases rose 9662.16% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 9662.16% YoY) and the FY2025 annual result came in at $3.6 million, up 4.62% from the prior year.
- Current Leases grew to $3.6 million in Q1 2026, from $3.6 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $3.6 million in Q1 2026 to a low of $5000.0 in Q1 2024.
- A 5-year average of $2.5 million and a median of $3.2 million in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases jumped 10653.85% — and 2024, when it tumbled 99.84%.
- Tracing ALGS's Current Leases over 5 years: stood at $3.0 million in 2022, then grew by 6.39% to $3.2 million in 2023, then rose by 5.98% to $3.4 million in 2024, then rose by 4.62% to $3.6 million in 2025, then rose by 0.89% to $3.6 million in 2026.
- The last three Current Leases figures came in at $3.6 million (Q1 2026), $3.6 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Aligos Therapeutics | 67.38 Mn | 36.94 Mn | - | 3.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.15 Mn |
| Mar 31, 2026 | 3.61 Mn |
| Dec 31, 2025 | 3.58 Mn |
| Sep 30, 2025 | 3.54 Mn |
| Jun 30, 2025 | 38,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 3.42 Mn |
| Sep 30, 2024 | 3.39 Mn |
| Jun 30, 2024 | 3.35 Mn |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 3.23 Mn |
| Sep 30, 2023 | 3.20 Mn |
| Jun 30, 2023 | 3.17 Mn |
| Mar 31, 2023 | 3.04 Mn |
| Dec 31, 2022 | 3.04 Mn |
| Sep 30, 2022 | 3.07 Mn |
| Jun 30, 2022 | 2.80 Mn |
| Mar 31, 2022 | 138,000.00 |
| Dec 31, 2021 | 138,000.00 |
| Sep 30, 2021 | 81,000.00 |